STAT3 as a potential immunotherapy biomarker in oncogene-addicted non-small cell lung cancer

STAT3 as a potential immunotherapy biomarker in oncogene-addicted non-small cell lung cancer

Immune checkpoint blockade has modified the treatment landscape for many types of tumors, including lung cancer. Still our knowledge on the biology of the interaction between tumor cells and the microenvironment is limited, preventing the optimal use of these new compounds and the maximum benefit th...

Full description

Bibliographic Details
Main Authors:	Ilaria Attili, Niki Karachaliou, Laura Bonanno, Jordi Berenguer, Jillian Bracht, Jordi Codony-Servat, Carles Codony-Servat, Masaoki Ito, Rafael Rosell
Format:	Article
Language:	English
Published:	SAGE Publishing 2018-03-01
Series:	Therapeutic Advances in Medical Oncology
Online Access:	https://doi.org/10.1177/1758835918763744

Similar Items

Targeting PKCι-PAK1 signaling pathways in EGFR and KRAS mutant adenocarcinoma and lung squamous cell carcinoma
by: Masaoki Ito, et al.
Published: (2019-10-01)

Common Co-activation of AXL and CDCP1 in EGFR-mutation-positive Non-smallcell Lung Cancer Associated With Poor Prognosis
by: Niki Karachaliou, et al.
Published: (2018-03-01)

AURKB as a target in non-small cell lung cancer with acquired resistance to anti-EGFR therapy
by: Jordi Bertran-Alamillo, et al.
Published: (2019-04-01)

Biological insights in non-small cell lung cancer
by: Rafael Rosell, et al.
Published: (2023-07-01)

Anti-epidermal growth factor vaccine antibodies increase the antitumor activity of kinase inhibitors in ALK and RET rearranged lung cancer cells
by: Jordi Codony-Servat, et al.
Published: (2021-01-01)

Evaluation of Biomarkers for HER3-targeted Therapies in Cancer
by: Niki Karachaliou, et al.
Published: (2015-03-01)

Targeting STAT3 and oxidative phosphorylation in oncogene-addicted tumors
by: Matilda Lee, et al.
Published: (2019-07-01)

Blockade of Stat3 oncogene addiction induces cellular senescence and reveals a cell-nonautonomous activity suitable for cancer immunotherapy
by: Mara De Martino, et al.
Published: (2020-01-01)

Vaccine antibodies against a synthetic epidermal growth factor variant enhance the antitumor effects of inhibitors targeting the MAPK/ERK and PI3K/Akt pathways
by: Silvia García-Roman, et al.
Published: (2024-02-01)

Oncogenic mutation or overexpression of oncogenic KRAS or BRAF is not sufficient to confer oncogene addiction.
by: Reina E Ito, et al.
Published: (2021-01-01)

Targeting the STAT3 oncogenic pathway: Cancer immunotherapy and drug repurposing
by: Yushan Dong, et al.
Published: (2023-11-01)

Combination of immunotherapy with targeted therapies in advanced non-small cell lung cancer (NSCLC)
by: Irene Moya-Horno, et al.
Published: (2018-01-01)

New Generations of Tyrosine Kinase Inhibitors in Treating NSCLC with Oncogene Addiction: Strengths and Limitations
by: Ilaria Attili, et al.
Published: (2023-10-01)

Author Correction: BIM and mTOR expression levels predict outcome to erlotinib in EGFR-mutant non-small-cell lung cancer
by: Niki Karachaliou, et al.
Published: (2023-03-01)

<i>BRAF</i> Mutations Classes I, II, and III in NSCLC Patients Included in the SLLIP Trial: The Need for a New Pre-Clinical Treatment Rationale
by: Jillian Wilhelmina Paulina Bracht, et al.
Published: (2019-09-01)

Src-Homology 2 Domain-Containing Phosphatase 2 in Resected EGFR Mutation-Positive Lung Adenocarcinoma
by: Masaoki Ito, MD, et al.
Published: (2020-11-01)

Science and biology drives the immune system to cure lung cancer patients: a revolution but not without challenges
by: Niki Karachaliou, et al.
Published: (2018-03-01)

Systemic treatment in EGFR-ALK NSCLC patients: second line therapy and beyond
by: Niki Karachaliou, et al.
Published: (2014-09-01)

Unmet Medical Needs in Non-Small-Cell Lung Cancer Treatment: How to Design Pre-Emptive Combination Therapies
by: Niki Karachaliou, et al.
Published: (2014-11-01)

Hypoxia-induced therapy resistance: Available hypoxia-targeting strategies and current advances in head and neck cancer
by: Victoria L. Codony, et al.
Published: (2021-03-01)

Assays for predicting and monitoring responses to lung cancer immunotherapy
by: Cristina Teixidó, et al.
Published: (2015-06-01)

Erratum to Assays for predicting and monitoring responses to lung cancer immunotherapy
by: Cristina Teixidó, et al.
Published: (2015-09-01)

Toopchi Bashof and Meskowich
by: mansur servat
Published: (2007-11-01)

Is Immunotherapy Beneficial in Patients with Oncogene-Addicted Non-Small Cell Lung Cancers? A Narrative Review
by: David John McMahon, et al.
Published: (2024-01-01)

Educación para el trabajo: alianza entre el liceo técnico-profesional y la empresa
by: Berta Servat Poblete
Published: (2002-10-01)

FORMACIÓN DE LOS PROFESIONALES DE LA EDUCACIÓN. ESTRATEGIAS DE GESTIÓN EN CENTROS ESCOLARES
by: Berta Servat Poblete
Published: (2007-04-01)

Advanced Glycations End Products in the Skin as Biomarkers of Cardiovascular Risk in Type 2 Diabetes
by: Alejandra Planas, et al.
Published: (2022-06-01)

Advances in immunotherapy for treatment of lung cancer
by: Jean G. Bustamante Alvarez, et al.
Published: (2015-09-01)

Clinical biomarkers directing the management of patients with colon and lung cancer (beyond oncogene-addicted NSCLC)
by: Ntanasis-Stathopoulos Ioannis, et al.
Published: (2020-09-01)

Pharmacological Inhibition of Oncogenic STAT3 and STAT5 Signaling in Hematopoietic Cancers
by: Marie Brachet-Botineau, et al.
Published: (2020-01-01)

Targeting Non-Oncogene Addiction for Cancer Therapy
by: Hae Ryung Chang, et al.
Published: (2021-01-01)

CD137+ and regulatory T cells as independent prognostic factors of survival in advanced non-oncogene addicted NSCLC patients treated with immunotherapy as first-line
by: Alain Gelibter, et al.
Published: (2024-04-01)

Analytical methods of oxysterol determination
by: F. Guardiola, et al.
Published: (1994-06-01)

Dietary n-6- or n-3-rich vegetable fats and α-tocopheryl acetate: effects on fatty acid composition and stability of rabbit plasma, liver and meat
by: A. Tres, et al.
Published: (2009-01-01)

Oxidized oils and dietary zinc and α-tocopheryl acetate supplementation: effects on rabbit plasma, liver and meat fatty acid composition and meat Zn, Cu, Fe and Se content
by: A. Tres, et al.
Published: (2010-01-01)

Trans isomers contents of the fatty acids in meat products. (I) Sausages
by: N. Hernández, et al.
Published: (1991-04-01)

Cholesterol oxidation products: biological effects; formation, content and determination in food
by: F. Guardiola, et al.
Published: (1991-02-01)

Combination of immunotherapy with chemotherapy and radiotherapy in lung cancer: is this the beginning of the end for cancer?
by: Chiara Lazzari, et al.
Published: (2018-04-01)

The Impacts of Vocabulary Instruction via Synchronous and Asynchronous Social Networks on Iranian EFL Learners' Reading Comprehension
by: Servat Shirkhani, et al.
Published: (2023-06-01)

Pragmatic Corrective Feedback in L2 Classrooms: Investigating EFL Teachers' Perceptions and Instructional Practices
by: Servat Shirkhani, et al.
Published: (2017-10-01)